Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Spark Therapeutics
Pharma
Pfizer charges $3.5M for its first FDA-approved gene therapy
Pfizer has gained its first FDA approval for a gene therapy, scoring with Beqvez for hemophilia B and will charge $3.5M for the one-time therapy.
Kevin Dunleavy
Apr 26, 2024 10:19am
Roche, bluebird settle gene therapy trademark suit
May 18, 2022 11:26am
Roche loses one bid against bluebird's 'spark' DTC ad
Jan 26, 2022 12:02pm
Biotech Sparx to build 1.2 million square foot plant in China
Jul 8, 2021 9:58am
Bluebird counters trademark suit from Roche's Spark
Jul 7, 2021 10:45am
Fierce 15 winner Senti is picking up a factory all its own
Jun 25, 2021 9:55am
